Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Palatin Technologies
(NY:
PTN
)
0.8709
-0.0391 (-4.30%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
223,267
Open
0.9159
Bid (Size)
0.8403 (11)
Ask (Size)
0.8990 (20)
Prev. Close
0.9100
Today's Range
0.8500 - 0.9599
52wk Range
0.6800 - 5.650
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's Intraday Session
September 27, 2024
Via
Benzinga
Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions
August 29, 2024
Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions
Via
News Direct
Exposures
Product Safety
Performance
YTD
-77.44%
-77.44%
1 Month
-41.55%
-41.55%
3 Month
-50.80%
-50.80%
6 Month
-58.13%
-58.13%
1 Year
-49.37%
-49.37%
More News
Read More
PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024
May 15, 2024
Via
InvestorPlace
Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
April 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Earnings Preview: Palatin Techs
February 14, 2024
Via
Benzinga
Recap: Palatin Techs Q1 Earnings
November 14, 2023
Via
Benzinga
Palatin Techs's Earnings Outlook
November 13, 2023
Via
Benzinga
Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
April 08, 2024
Via
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 28, 2024
Via
Benzinga
Palatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummets
February 28, 2024
Via
Benzinga
Dow Dips 200 Points; TJX Posts Upbeat Sales
February 28, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 15, 2024
Via
Benzinga
The 3 Best Penny Stocks to Buy in February 2024
February 15, 2024
Via
InvestorPlace
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
February 01, 2024
Via
InvestorPlace
3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
January 11, 2024
Via
InvestorPlace
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
January 03, 2024
From
Cosette Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 27, 2023
Via
Benzinga
Analysts Say 3 Stocks Have a Combined Upside of 3000%
December 23, 2023
Via
InvestorPlace
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 15, 2023
Via
InvestorPlace
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
October 19, 2023
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.